BRPI0510906A - composição farmacêutica tópica, composição para administração tópica e seu uso - Google Patents
composição farmacêutica tópica, composição para administração tópica e seu usoInfo
- Publication number
- BRPI0510906A BRPI0510906A BRPI0510906-0A BRPI0510906A BRPI0510906A BR PI0510906 A BRPI0510906 A BR PI0510906A BR PI0510906 A BRPI0510906 A BR PI0510906A BR PI0510906 A BRPI0510906 A BR PI0510906A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- topical
- pharmaceutical composition
- topical administration
- topical pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPOSIçãO FARMACêUTICA TóPICA, COMPOSIçãO PARA ADMINISTRAçãO TóPICA E SEU USO. A presente invenção provê uma composição tópica compreendendo (a) pelo menos um composto agente de liberação e (b) um componente de cromolina. Também são providos métodos de tratamento e métodos para preparar a composição tópica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57289604P | 2004-05-19 | 2004-05-19 | |
PCT/US2005/017816 WO2005112943A1 (en) | 2004-05-19 | 2005-05-19 | Topical cromolyn formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0510906A true BRPI0510906A (pt) | 2007-11-06 |
Family
ID=35428246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0510906-0A BRPI0510906A (pt) | 2004-05-19 | 2005-05-19 | composição farmacêutica tópica, composição para administração tópica e seu uso |
Country Status (11)
Country | Link |
---|---|
US (1) | US9498487B2 (pt) |
EP (1) | EP1750721A4 (pt) |
JP (1) | JP4885856B2 (pt) |
CN (1) | CN1968704B (pt) |
AU (2) | AU2005244986B2 (pt) |
BR (1) | BRPI0510906A (pt) |
CA (1) | CA2566747C (pt) |
MX (1) | MXPA06013384A (pt) |
NZ (2) | NZ551597A (pt) |
WO (1) | WO2005112943A1 (pt) |
ZA (1) | ZA200610332B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7758901B2 (en) * | 2007-02-16 | 2010-07-20 | Betty Bellman | Compositions and methods for alleviating skin disorders |
JP6265998B2 (ja) | 2012-09-17 | 2018-01-24 | ネクター セラピューティクス | オリゴマー含有ベンズアミド系化合物 |
ES2653787B1 (es) * | 2016-07-07 | 2018-09-25 | Diater Laboratorio De Diagnóstico Y Aplicaciones Terapéuticas, S.A. | Composiciones de ácido cromoglícico para el tratamiento de la dermatitis |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61106509A (ja) * | 1984-10-29 | 1986-05-24 | Fujisawa Pharmaceut Co Ltd | 鼻腔用医薬組成物 |
JPS61246117A (ja) * | 1985-04-22 | 1986-11-01 | Masako Motomura | 抗アレルギ−点眼薬 |
JPS63255221A (ja) * | 1987-04-13 | 1988-10-21 | Nippon Tenganyaku Kenkyusho:Kk | 外用クロモグリク酸ナトリウム製剤 |
US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US6099856A (en) | 1992-06-15 | 2000-08-08 | Emisphere Technologies, Inc. | Active agent transport systems |
US5541155A (en) | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
ATE204467T1 (de) | 1993-04-22 | 2001-09-15 | Emisphere Tech Inc | Orale darreichungsform |
US5866536A (en) * | 1995-03-31 | 1999-02-02 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
WO1997036480A1 (en) | 1996-03-29 | 1997-10-09 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5576346A (en) * | 1995-04-03 | 1996-11-19 | Ascent Pharmaceuticals, Inc. | Process for treating uremic pruritus |
US5820881A (en) | 1995-04-28 | 1998-10-13 | Emisphere Technologies, Inc. | Microspheres of diamide-dicarboxylic acids |
EP0883629A1 (en) | 1996-02-29 | 1998-12-16 | Emisphere Technologies, Inc. | Oligopeptides for drug delivery |
CA2243643A1 (en) | 1996-11-18 | 1998-05-28 | Susan Haas | Methods and compositions for inducing oral tolerance in mammals |
US5773647A (en) * | 1997-02-07 | 1998-06-30 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
DK1093819T3 (da) * | 1997-02-07 | 2006-09-11 | Emisphere Tech Inc | Forbindelse og præparat til tilförsel af aktive midler |
US5863944A (en) | 1997-04-30 | 1999-01-26 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
JPH11335281A (ja) * | 1998-05-22 | 1999-12-07 | Sekisui Chem Co Ltd | 皮膚疾患治療用外用剤 |
GB9810949D0 (en) | 1998-05-22 | 1998-07-22 | Hewlett Healthcare Limited | Formulation |
EP1100522B1 (en) | 1998-07-27 | 2016-12-07 | Emisphere Technologies, Inc. | Pulmonary delivery of active agents |
KR100659753B1 (ko) | 1998-08-07 | 2006-12-20 | 에미스페어 테크놀로지스, 인코포레이티드 | 활성제 전달용 화합물 및 조성물 |
DE19837869C1 (de) | 1998-08-20 | 2000-05-11 | Siemens Ag | Schaltvorrichtung zum Zu- und Abschalten oder Erden von Streckenabschnitten bei Fahrleitungsanlagen |
IL143962A0 (en) * | 1999-01-08 | 2002-04-21 | Emisphere Tech Inc | Polymeric delivery agents and delivery agent compounds |
WO2000046182A1 (en) | 1999-02-05 | 2000-08-10 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides |
DE60024414T2 (de) | 1999-02-11 | 2006-06-14 | Emisphere Tech Inc | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen |
WO2000048589A1 (en) | 1999-02-22 | 2000-08-24 | Emisphere Holdings, Inc. | Solid oral dosage form containing heparin or a heparinoid in combination with a carrier |
EP1163209A4 (en) | 1999-02-26 | 2004-12-29 | Emisphere Tech Inc | COMPOUNDS AND COMPOSITIONS FOR ADMINISTRATION OF ACTIVE INGREDIENTS |
WO2000051605A1 (en) * | 1999-03-01 | 2000-09-08 | Schering Corporation | Compositions and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids |
AU4218400A (en) | 1999-04-05 | 2000-10-23 | Emisphere Technologies, Inc. | Lyophilized solid dosage forms and methods of making |
CA2369591C (en) | 1999-04-05 | 2011-06-14 | Emisphere Technologies, Inc. | Disodium salts, monohydrate, and ethanol solvates |
WO2001012183A1 (en) * | 1999-08-16 | 2001-02-22 | Merck & Co., Inc. | Heterocycle amides as cell adhesion inhibitors |
CZ20021554A3 (cs) | 1999-11-05 | 2002-10-16 | Emisphere Technologies, Inc. | Deriváty fenoxykarboxylové sloučeniny a prostředky pro dodávání aktivní sloľky |
WO2001034114A1 (en) | 1999-11-12 | 2001-05-17 | Emisphere Technologies, Inc. | Liquid heparin formulation |
DE60038183T2 (de) | 1999-12-16 | 2009-02-19 | Emisphere Technologies, Inc. | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe |
WO2001051454A1 (en) | 2000-01-13 | 2001-07-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6225356B1 (en) * | 2000-01-20 | 2001-05-01 | Jones, Iii Tudor | Cromolyn sodium containing composition and method of treatment for vilvar vestibulitis interstitial cystitis vukvar vaginitis and vaginitis dynea |
ATE554062T1 (de) | 2000-03-21 | 2012-05-15 | Emisphere Tech Inc | Verfahren zur herstellung von alkylierten salicylamiden durch ein dicarboxylat- zwischenprodukt |
US7262325B2 (en) | 2000-06-02 | 2007-08-28 | Emisphere Technologies, Inc. | Method of preparing salicylamides |
US7227033B2 (en) | 2002-01-09 | 2007-06-05 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
MXPA02012855A (es) | 2000-06-29 | 2004-04-20 | Emisphere Tech Inc | Compuestos y composiciones para suministrar agentes activos. |
EP1317412A1 (en) | 2000-08-18 | 2003-06-11 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US6846844B2 (en) | 2000-08-18 | 2005-01-25 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2002019969A2 (en) | 2000-09-06 | 2002-03-14 | Emisphere Technologies Inc. | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents |
WO2002020466A1 (en) | 2000-09-06 | 2002-03-14 | Emisphere Technologies, Inc. | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
US7049283B2 (en) * | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
BR0207871A (pt) | 2001-03-01 | 2004-06-22 | Emisphere Tech Inc | Composição para liberar bisfosfonato para um alvo |
WO2002100338A2 (en) | 2001-06-08 | 2002-12-19 | Emisphere Technologies, Inc. | Compound and composition for delivering active agents |
JP2003246737A (ja) * | 2001-08-09 | 2003-09-02 | Sekisui Chem Co Ltd | 皮膚外用組成物 |
CN100516020C (zh) * | 2001-09-26 | 2009-07-22 | 艾米斯菲尔技术有限公司 | 通过二羧化物中间体制备苯氧基链烷酸、链烯酸和炔酸及其盐的方法 |
AU2002360387B2 (en) | 2001-11-13 | 2008-08-07 | Emisphere Technologies, Inc. | Phenoxy amine compounds and compositions for delivering active agents |
US20040259952A1 (en) * | 2001-11-29 | 2004-12-23 | Richat Abbas | Formulations for oral administration of cromolyn sodium |
US20030198666A1 (en) | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
JP2006528982A (ja) * | 2003-05-14 | 2006-12-28 | エミスフェアー・テクノロジーズ・インク | ペプチドyyおよびpyy作用薬の送達用組成物 |
-
2005
- 2005-05-19 EP EP05752032A patent/EP1750721A4/en not_active Withdrawn
- 2005-05-19 BR BRPI0510906-0A patent/BRPI0510906A/pt not_active IP Right Cessation
- 2005-05-19 WO PCT/US2005/017816 patent/WO2005112943A1/en active Application Filing
- 2005-05-19 NZ NZ551597A patent/NZ551597A/en not_active IP Right Cessation
- 2005-05-19 MX MXPA06013384A patent/MXPA06013384A/es not_active Application Discontinuation
- 2005-05-19 AU AU2005244986A patent/AU2005244986B2/en not_active Ceased
- 2005-05-19 CN CN2005800193709A patent/CN1968704B/zh not_active Expired - Fee Related
- 2005-05-19 US US11/569,285 patent/US9498487B2/en not_active Expired - Fee Related
- 2005-05-19 NZ NZ588373A patent/NZ588373A/en not_active IP Right Cessation
- 2005-05-19 JP JP2007527493A patent/JP4885856B2/ja not_active Expired - Fee Related
- 2005-05-19 CA CA2566747A patent/CA2566747C/en not_active Expired - Fee Related
-
2006
- 2006-12-11 ZA ZA200610332A patent/ZA200610332B/en unknown
-
2011
- 2011-04-27 AU AU2011201896A patent/AU2011201896B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2011201896B2 (en) | 2012-03-15 |
EP1750721A4 (en) | 2012-10-31 |
CN1968704B (zh) | 2010-12-08 |
US20090209635A1 (en) | 2009-08-20 |
EP1750721A1 (en) | 2007-02-14 |
ZA200610332B (en) | 2007-12-27 |
AU2005244986B2 (en) | 2011-01-27 |
US9498487B2 (en) | 2016-11-22 |
CA2566747A1 (en) | 2005-12-01 |
AU2011201896A1 (en) | 2011-05-19 |
JP4885856B2 (ja) | 2012-02-29 |
AU2005244986A1 (en) | 2005-12-01 |
NZ551597A (en) | 2010-11-26 |
WO2005112943A1 (en) | 2005-12-01 |
MXPA06013384A (es) | 2007-03-01 |
JP2007538101A (ja) | 2007-12-27 |
NZ588373A (en) | 2012-01-12 |
CN1968704A (zh) | 2007-05-23 |
CA2566747C (en) | 2015-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0510170B8 (pt) | composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto | |
DOP2006000268A (es) | Agentes antibacterianos | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
CL2004000930A1 (es) | Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos. | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
BRPI0514474A (pt) | multiparticulados | |
CL2007003244A1 (es) | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
NI200600290A (es) | Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso | |
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
CL2004000416A1 (es) | Compuestos heterociclicos nitrogenados; composicion farmaceutica; y uso del compuesto para tratar o prevenir una condicion mediada por p38, que consiste en una enfermedad inflamatoria, autoinmune, virosica o neurodegenerativa. | |
HUP0303271A2 (hu) | Rapamycin felhasználása rák kezelésére alkalmas gyógyszerkészítmény elõállítására | |
UY29086A1 (es) | Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos. | |
CL2007002018A1 (es) | Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular. | |
CL2004001069A1 (es) | Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii. | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BRPI0821004A8 (pt) | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste | |
CL2007003557A1 (es) | Compuestos derivados de heterociclos de nitrogeno, inhibidores de la actividad sobre b-raf; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
EP1827446A4 (en) | SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND URETINS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHOD FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS WITH ARENA VIRUSES | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CY1111369T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολη και παρακεταμολη | |
NO20071871L (no) | Fosfoindoler som HIV-inhibitorer. | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
ATE475408T1 (de) | Formulierungen von tipifarnib zur intravenösen verabreichung | |
CL2004001012A1 (es) | Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |